Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
China Journal of Chinese Materia Medica ; (24): 4309-4312, 2015.
Article in Chinese | WPRIM | ID: wpr-279242

ABSTRACT

In order to reaction the quality present situation, problems on the current quality of animal sources of drugs are summed up by using test data analysis, literature search and marketing research. This paper can also help the improvement of the quality management, the revision of the relevant department policy system and the improvement of standards.


Subject(s)
Animals , China , Medicine, Chinese Traditional , Reference Standards , Pharmaceutical Preparations , Reference Standards , Quality Control
2.
Chinese Journal of Plastic Surgery ; (6): 161-164, 2012.
Article in Chinese | WPRIM | ID: wpr-246878

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the efficacy and side effect of topical beta-blocker (Timolol Maleate) in the treatment of periocular hemangioma in a prospective study.</p><p><b>METHODS</b>432 outpatients with infantile hemangioma visited our special clinic service in Shanghai Ninth People's Hospital from July 2010 to December 2011. Among them, 12 superficial periocular lesions were selected in the study. Timolol was used topically on the lesion in every 12 hours. Two independent special doctors evaluated the results according to the pictures before and after four-week application of timolol.</p><p><b>RESULTS</b>Were categorized into four levels: continuous growth (the lesion continues to grow), stable (no visible change), moderate (0-50% of regression) , perfect (more than 50% of improvement). Result of the 12 outpatients, 4 showed perfect result, 2 moderate, 4 stable and 2 continuous growth. No side effect was observed.</p><p><b>CONCLUSIONS</b>Topical timolol is effective and safe in the treatment of superficial periocular infantile hemangioma. It could be considered as the first line treatment of proliferative superficial hemangioma.</p>


Subject(s)
Humans , Infant , Administration, Topical , Angiogenesis Inhibitors , Therapeutic Uses , China , Facial Neoplasms , Drug Therapy , Pathology , Hemangioma , Drug Therapy , Pathology , Hemangioma, Capillary , Drug Therapy , Pathology , Prospective Studies , Skin Neoplasms , Drug Therapy , Pathology , Timolol , Therapeutic Uses , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL